ANI Pharmaceuticals, Inc. (ANIP)

ANI Pharmaceuticals Revenue

ANI Pharmaceuticals had revenue of $211.37M in the quarter ending June 30, 2025, with 53.12% growth. This brings the company's revenue in the last twelve months to $747.40M, up 38.68% year-over-year. In the year 2024, ANI Pharmaceuticals had annual revenue of $614.38M with 26.20% growth.

• Revenue (ttm): $747.40M
• Revenue Growth: +38.68%
• P/S Ratio: 2.42
• Revenue / Employee: $833,221
• Employees: 897
• Market Cap: 1.86B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	614.38M	127.56M	26.20%
Dec 31, 2023	486.82M	170.43M	53.87%
Dec 31, 2022	316.39M	100.25M	46.38%
Dec 31, 2021	216.14M	7.66M	3.67%
Dec 31, 2020	208.48M	1.93M	0.93%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.